Skip to main content
search

February 26, 2026

Metadata used to be an afterthought. Today, it’s the architecture of data confidence.

In clinical research, metadata is no longer just the “glue” holding documents together. It defines how data is created, transformed, validated, and reused across studies. As CDISC standards mature and regulatory expectations for transparency and traceability increase, organizations are realizing that success depends on treating metadata not as documentation—but as infrastructure.

This shift was a central theme of our recent webinar, Metadata as Infrastructure: Designing for Reuse, Insight, and Auditability, hosted by Trevor Mankus, a recognized expert in clinical data standards. His message was clear: scalable, audit-ready data operations are not built at submission; they are designed upstream, starting with metadata.

At Pinnacle 21, we see this transformation every day. Organizations that invest in a robust metadata strategy don’t just improve compliance. They build systems that scale, adapt, and earn trust across studies and over time.

Stage 1: Documented - Metadata as Recordkeeping

Every organization starts here. Metadata lives in specifications, spreadsheets, and versioned files, often scattered across teams and studies. It is technically “managed,” but not structured for reuse, governance, or long-term traceability.

Common challenges at this stage include:

  • Inconsistent variable naming and definitions
  • Limited visibility into derivations across studies
  • Repeated effort to recreate datasets and validation rules
  • Lengthy review and audit cycles driven by manual explanation

In this model, metadata serves primarily as historical evidence. It documents what happened, but it does little to prevent errors, accelerate study startup, or support reuse.

During the webinar, Trevor Mankus highlighted a critical issue organizations often overlook: many audit and reuse problems don’t stem from incorrect data, they stem from missing context. When metadata exists only as static documentation, teams are forced to reconstruct intent long after decisions were made.

If your metadata lives on a shared drive, your efficiency is trapped there too.

To move forward, organizations must shift from documenting metadata to designing with metadata.

Stage 2: Governed - Metadata as a Shared Language

As organizations mature, governance becomes essential. This is where metadata evolves from individual knowledge into an enterprise-wide asset.

Governed metadata establishes:

  • Clear ownership and accountability
  • Standard definitions and controlled terminology
  • Versioning with historical context
  • Traceability across studies and standards

A centralized metadata repository (MDR) becomes the single source of truth for variables, derivations, validation rules, and their relationships.

One of Trevor’s key points during the webinar was that deviations from standards are inevitable and not inherently problematic. What matters is whether those deviations are intentional, visible, and traceable. Governance does not eliminate flexibility; it makes flexibility auditable.

For clinical programmers, governed metadata enables:

  • Standardized dataset templates
  • Automated mapping and rule reuse
  • Faster response to evolving regulatory requirements

For biostatisticians, it supports:

  • Consistent variable definitions across studies
  • Clear lineage for derived variables and analysis outputs
  • Simplified QC and audit readiness

At this stage, metadata becomes a shared language across teams. When everyone works from the same definitions and version history, collaboration improves and explanation becomes the exception rather than the rule.

Stage 3: Dynamic - Metadata as Infrastructure

At the highest level of maturity, metadata does more than support processes; it drives them.

This is where metadata becomes true infrastructure.

  • Automation: Dataset generation, validation, and Define.xml creation are triggered directly from governed metadata libraries.
  • Reuse: Standard components cascade across new studies, accelerating startup while preserving consistency.
  • Auditability: Every transformation, rule, and version change is logged, embedding traceability into the system.
  • Insight: Metadata itself becomes analyzable, revealing bottlenecks, trends, and opportunities for optimization.

As Trevor emphasized, audit readiness is not about perfection, it’s about traceability over time. Knowing which standard applied when, and why decisions were made, is what allows organizations to respond confidently to regulators.

At this level, metadata no longer follows the data. It leads it.

One sponsor reported that after implementing a centralized metadata infrastructure, study build timelines decreased by 35%, while validation findings dropped by nearly half. These gains weren’t achieved through shortcuts or additional oversight, they came from reusing trust.

Turning Metadata Strategy into Reality

Building a scalable metadata strategy is an iterative process that requires alignment across people, process, and technology.

Organizations making progress typically focus on:

  • Assessing metadata maturity: Identifying gaps in governance, standardization, and traceability
  • Starting small: Piloting a single domain (such as SDTM or ADaM) or a specific process like validation rules
  • Establishing governance early: Defining ownership, approval workflows, and versioning practices
  • Investing in training: Helping teams understand why metadata matters, not just how to manage it
  • Automating incrementally: Introducing rule-based automation and controlled terminology synchronization over time

As discussed in the webinar, the goal is not to build a perfect system on day one. It’s to build a system that can learn, adapt, and scale.

Metadata maturity grows through iteration.

The Future of Clinical Data: Metadata as the Language of Science

As the volume, complexity, and velocity of clinical data continue to increase, metadata is becoming the universal language connecting systems, standards, and people. It bridges operational rigor and scientific insight—enabling faster submissions, cleaner audits, and more reliable analytics.

Metadata doesn’t just describe your data, it defines your credibility. Organizations that invest in metadata infrastructure today won’t just keep pace with regulatory change. They’ll be positioned to lead it.

Watch the full recording of Metadata as Infrastructure: Designing for Reuse, Insight, and Auditability, featuring Trevor Mankus, and learn how Pinnacle 21 Enterprise helps teams turn metadata into measurable, repeatable value.

Because the best infrastructure doesn’t just support your work—it strengthens your results.

Author

Trevor Mankus

Trevor Mankus

Product Manager, Pinnacle 21 by Certara
As a Product Manager at Certara, Trevor Mankus helps deliver value to customers via improvements to Pinnacle 21 software. Trevor identifies problems and opportunities and then directs our engineering R&D efforts at these areas to help create the most value — optimizing complex trade-offs in the process. Product managers sit at the intersection of business, UX design, and technology. Prior to his time at Certara, he enjoyed working in the healthcare industry at various Pharmaceuticals and CROs as a clinical programmer.
Trevor has been an active CDISC member since 2009 focusing primarily in the ADaM project. He was selected to be the future CDISC ADaM team lead (2026-2027) and has been co-leading the CDISC ADaM Conformance Rules sub-team for many years. Notable accomplishments include multiple publications of the CDISC ADaM conformance rules catalog.

Book a demo of Pinnacle 21